Kita Hiroto, Naidenko Olga V, Kronenberg Mitchell, Ansari Aftab A, Rogers Paul, He Xiao-Song, Koning Frits, Mikayama Toshifumi, Van De Water Judy, Coppel Ross L, Kaplan Marshall, Gershwin M Eric
Division of Rheumatology, Allergy, and Clinical Immunology, University of California, Davis, CA 95616, USA.
Gastroenterology. 2002 Oct;123(4):1031-43. doi: 10.1053/gast.2002.36020.
BACKGROUND & AIMS: Natural killer T (NKT) cells are a subset of lymphocytes incriminated in playing an important role in the modulation of the innate immune response and the development of autoimmunity. However, there have been only limited studies attempting to quantitate the number of NKT cells in autoimmune disease, particularly because of difficulties associated with definition of this subpopulation.
We used a human CD1d (hCD1d) tetramer produced by a baculovirus expressing recombinant CD1d protein complexed with alpha-galactosylceramide (alpha-GalCer) and quantitated hCD1d tetramer reactive cells in blood and liver from controls and patients with primary biliary cirrhosis (PBC).
The majority of CD1d-alphaGalCer-restricted NKT cells were positive for TCR Valpha24 and Vbeta11. There was a distinct CD4- CD8+ population within the CD1d-alphaGalCer-restricted NKT cells in addition to the CD4- CD8- and CD4+ CD8- population. The frequency of CD1d-alphaGalCer-restricted NKT cells was similar between blood and liver in healthy individuals. In contrast, the frequency of CD1d-alphaGalCer-restricted NKT cells in the liver was significantly higher than in the blood of PBC patients. The frequency of CD1d-alpha-GalCer-restricted NKT cells in the liver was also significantly higher in PBC patients than in healthy individuals.
The frequency and function of such cells should be studied not only in blood but also in the target organ of the autoimmune disease. Selective enrichment of CD1d-alphaGalCer-restricted NKT cells at the site of inflammation is observed in PBC, suggesting a role of these cells in the development of PBC.
自然杀伤T(NKT)细胞是淋巴细胞的一个亚群,在固有免疫反应调节和自身免疫发展中起重要作用。然而,仅有有限的研究试图对自身免疫性疾病中NKT细胞的数量进行定量,尤其是因为定义该亚群存在困难。
我们使用了一种由杆状病毒产生的人CD1d(hCD1d)四聚体,该杆状病毒表达与α-半乳糖神经酰胺(α-GalCer)复合的重组CD1d蛋白,并对来自对照组和原发性胆汁性肝硬化(PBC)患者的血液和肝脏中的hCD1d四聚体反应性细胞进行定量。
大多数受CD1d-αGalCer限制的NKT细胞对TCR Vα24和Vβ11呈阳性。除了CD4-CD8-和CD4+CD8-群体外,在受CD1d-αGalCer限制的NKT细胞中还有一个独特的CD4-CD8+群体。健康个体血液和肝脏中受CD1d-αGalCer限制的NKT细胞频率相似。相比之下,PBC患者肝脏中受CD1d-αGalCer限制的NKT细胞频率显著高于血液中的频率。PBC患者肝脏中受CD1d-α-GalCer限制的NKT细胞频率也显著高于健康个体。
不仅应在血液中,还应在自身免疫性疾病的靶器官中研究此类细胞 的频率和功能。在PBC中观察到炎症部位受CD1d-αGalCer限制的NKT细胞选择性富集,表明这些细胞在PBC发展中起作用。